Serum IGF-1 Scores and Clinical Outcomes in the Phase III IMbrave150 Study of Atezolizumab Plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma

PURPOSE: Child-Turcotte-Pugh class A (CTP-A) in unresectable hepatocellular carcinoma (HCC) is the standard criterion for active therapy and clinical trial enrollment. We hypothesized that insulin-like growth factor-1 (IGF-1) derived scores may provide improved survival prediction over CTP classific...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaseb, Ahmed O, Guan, Yinghui, Gok Yavuz, Betul, Abbas, Alexander R, Lu, Shan, Hasanov, Elshad, Toh, Han Chong, Verret, Wendy, Wang, Yulei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569161/
https://www.ncbi.nlm.nih.gov/pubmed/36254201
http://dx.doi.org/10.2147/JHC.S369951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569161/
https://www.ncbi.nlm.nih.gov/pubmed/36254201
http://dx.doi.org/10.2147/JHC.S369951

Ejemplares similares